User profiles for Juan P. Rocca
JUAN P. ROCCA, MD, MHA, FACSAssociate Professor of Surgery. Albert Einstein College of Medicine. Verified email at montefiore.org Cited by 2037 |
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways
The molecular and cellular processes that lead to renal damage and to the heterogeneity of
lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (…
lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (…
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation
ME Facciuto, B Koneru, JP Rocca, DC Wolf… - Annals of surgical …, 2008 - Springer
Background There is no clear consensus regarding the best treatment strategy for patients
with advanced hepatocellular carcinoma (HCC). Methods Patients with cirrhosis and HCC …
with advanced hepatocellular carcinoma (HCC). Methods Patients with cirrhosis and HCC …
[HTML][HTML] Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
…, J Hyun, S Khan, M Wood, B Samstein, JP Rocca… - Oncogene, 2023 - nature.com
In patients with locally advanced cancer without distant metastases, the neoadjuvant setting
presents a platform to evaluate new drugs. For mismatch repair proficient/microsatellite …
presents a platform to evaluate new drugs. For mismatch repair proficient/microsatellite …
Exploring the usage of a mobile phone application in transplanted patients to encourage medication compliance and education
…, A Rizzo, N Hayde, AC Watkins, JP Rocca… - The American Journal of …, 2017 - Elsevier
Background Medication non-adherence in transplant patients is a grave problem that results
in increased rejection episodes, graft loss and significant morbidity. Methods The efficacy of …
in increased rejection episodes, graft loss and significant morbidity. Methods The efficacy of …
Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches
The high rate of immunosuppressive medication non-adherence in transplant recipients
demands the search for a solution that targets modifiable risk factors and incorporates mobile …
demands the search for a solution that targets modifiable risk factors and incorporates mobile …
Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients
Introduction The advent of direct‐acting antivirals (DAAs) has created an avenue for
transplantation of hepatitis C virus (HCV)‐infected donors into uninfected recipients (D+/R−). The …
transplantation of hepatitis C virus (HCV)‐infected donors into uninfected recipients (D+/R−). The …
The abdominal transplant surgery workforce: current state and future trends
Transplant surgical workforce concerns have arisen in the last 5 years as reflected in
challenges securing job opportunities for new fellows. The present survey was designed by the …
challenges securing job opportunities for new fellows. The present survey was designed by the …
Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction
…, MI Rodriguez-Davalos, MK Singh, JP Rocca… - Surgery, 2009 - Elsevier
BACKGROUND: Meso-Rex bypass is used to treat patients with clinically important extrahepatic
portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is …
portal vein obstruction (EHPVO). Usually, an autologous left internal jugular vein graft is …
Transplantation of viral‐positive hepatitis C‐positive kidneys into uninfected recipients offers an opportunity to increase organ access
…, JF Reinus, MM Kinkhabwala, JP Rocca - Clinical …, 2020 - Wiley Online Library
The advent of direct‐acting antivirals (DAAs) has provided the impetus to transplant kidneys
from hepatitis C virus‐positive donors into uninfected recipients (D+/R−). Thirty D+/R− …
from hepatitis C virus‐positive donors into uninfected recipients (D+/R−). Thirty D+/R− …
Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications
M Facciuto, A Contreras-Saldivar, MK Singh, JP Rocca… - Surgery, 2013 - Elsevier
BACKGROUND: Extensive attention has been placed on remnant liver volume (RLV) above
other factors to ensure donor safety. METHODS: We performed a retrospective review of …
other factors to ensure donor safety. METHODS: We performed a retrospective review of …